Aspen Aerogels (ASPN) Form 3 ASPEN AEROGELS / Gregg Landes ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Landes Gregg

(Last) (First) (Middle)

C/O ASPEN AEROGELS, INC.

30 FORBES ROAD, BUILDING B

(Street)

NORTHBOROUGH MA 01532

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/28/2018

3. Issuer Name and Ticker or Trading Symbol
ASPEN AEROGELS INC [ ASPN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP, Innovation & Strategic Dev

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,407(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(2)	11/02/2026	Common Stock	18,971	6.04	D
Stock Options (right to buy)	(3)	02/28/2027	Common Stock	27,308	4.14	D

Explanation of Responses:

1. Represents 7,802 shares of common stock and 15,605 restricted stock units ("RSU"). Each RSU represents the right to receive one share of common stock upon vesting.

2. The options, originally granted on November 2, 2016, vested as to one-third of the shares on November 2, 2017, an additional one-third of the shares will vest on November 2, 2018 and the remaining one-third of the shares will vest on November 2, 2019.

3. The options, originally granted on February 28, 2017, vested as to one-third of the shares on February 28, 2018, an additional one-third of the shares will vest on February 28, 2019 and the remaining one-third of the shares will vest on February 28, 2020.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Poongunran Muthukumaran, Attorney-in-fact	03/02/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.